To proof this concept, we cocultured LSCs and CD8+ CTLs from CML BM in the presence and absence of CML Tregs and an agonistic Tnfrsf4 antibody followed by plating in methylcellulose. The gene discussed is CD8A; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.